Novedades en relación con la transparencia del precio de los medicamentos

Joan Carles Bailach, Jordi Faus

CUADERNOS DE DERECHO FARMACÉUTICO, NUM. 79, OCTOBER-DECEMBER 2021

The purpose of this article is to provide some analysis on the latest developments in the area of price transparency of medicines for human use. This article analyses a report issued by the Ministry of Health that defends maintaining a certain degree of confidentiality in the price of medicines, as well as the European Commission’s...
Read More

Dispensing vs. delivery of medicines

Judgment of the Supreme Court of 2 November 2021

Santiago Tomas

Capsulas Nº 222

Our CAPSULES of 23 June reported on the admission of a cassation appeal that granted the Supreme Court the opportunity to interpret the terms “dispensing” and “delivery” of medicines, which are hugely relevant to new business models and emerging platforms. The Judgment of 2 November 2021 resolves the appeal and offers interesting arguments as to...
Read More

When is an administrative decision deemed notified?

Judgement of the Supreme Court of 10 November 2021

Oriol Cases

Capsulas Nº 222

Background This case is about whether the beneficiary of a subsidy must return the subsidy to the Administration that granted it or not. The Administration considered that the subsidy must be returned because the beneficiary had not complied with its terms. The matter was brought before the Spanish Audiencia Nacional which ruled that the beneficiary...
Read More

Further clarity on the term of the statute of limitations for agency fees

Judgment of the Supreme Court of 23 November 2021

Juan Martínez, Lluís Alcover

Capsulas Nº 222

Background In the case of agency contracts, the agent promotes commercial transactions on behalf of the principal in exchange for a commission. Unless a more beneficial contractual provision for the agent exists, the commission accrues upon execution of the commercial transaction promoted by the agent (art. 14 of Law 12/1992). Payment must be made before...
Read More

Amendments to the Law of Unfair Competition: greater control of the online marketplace

Royal Decree-Law 24/2021 qualifies new practices in the area of imitations, searches and online reviews as unfair

Anna Gerboles

Capsulas Nº 222

Background Royal Decree-Law 24/2021, of 2 November, transposed several European directives into Spanish law, with a particular impact on consumer and commercial practices. This regulation makes various amendments to our legislation, including to the Retail Trade Law and the General Consumer and User Protection Act. In this article, we highlight the amendments made to Law...
Read More

Más medios para una mejor transparencia

Joan Carles Bailach

El Global

El Consejo de Transparencia y Buen Gobierno (CTBG) publicó, el pasado 30 de noviembre, su Plan Estratégico 2022-2025 donde se detallan, entre otras, sus principales líneas, objetivos y ejes de actuación para los próximos 4 años. Entre los objetivos estratégicos fijados destacan los siguientes: por un lado, adecuar y mejorar los recursos económicos y la estructura del CTBG a sus competencias y funciones;...
Read More

PSPs: luz al final del túnel

Lluís Alcover

El Global

Los programas de soporte a pacientes (PSPs), entendidos de manera amplia como cualquier programa que persigue atender necesidades de los pacientes y dotarles de herramientas que les permitan entender mejor su patología y/o su tratamiento así como mejorar sus resultados en salud, son una práctica cada vez más extendida en España.  El cambio de paradigma...
Read More

The European Council approves the final version of the Regulation on Health Technology Assessment

European assessment processes will be created to support budgetary decision-marking in healthcare

Anna Gerboles

Capsulas Nº 221

Background and scope On 9 November, the European Council gave its final go-ahead to the proposal for a Regulation on Health Technology Assessment (HTA), which the European Commission presented in January 2018 and was particularly promoted during the Portuguese Presidency in the first semester of 2021. The Regulation still needs to be adopted by the...
Read More

How the reference price system may apply for products with the same active ingredient but different potency

Judgement of the Supreme Court of 27 October 2021

Lluís Alcover

Capsulas Nº 221

Background We are approaching the 25th anniversary of the reference pricing system (RPS), which was first introduced in Spain by Law no. 13/1996. Hindsight allows us to draw one conclusion, among others: while the RPS has proved to be a useful tool to control pharmaceutical expenditure and ensure sustainability of the public healthcare system, applying...
Read More

Any unsuccessful tenderer can access documents related to the performance of a public contract

The judgment of the Spanish National High Court of 1 October 2021 contends that the way in which a contract is performed affects public interest

Joan Carles Bailach

Capsulas Nº 221

Background The judgment under analysis derives from Resolution no. 122/2019, of 25 March, of the Council of Transparency and Good Governance (CTBG, according to its Spanish acronym). A company that submitted a bid in the context of a public tender and was not awarded the contract requested the Ministry of Public Works and Transport to...
Read More

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información. ACEPTAR

Aviso de cookies